Skip to main content
Top
Published in: Current Pain and Headache Reports 11/2018

01-11-2018 | Uncommon and/or Unusual Headaches and Syndromes (J Ailani, Section Editor)

Current Aura Without Headache

Authors: Divya R. Shah, Sonam Dilwali, Deborah I. Friedman

Published in: Current Pain and Headache Reports | Issue 11/2018

Login to get access

Abstract

Purpose of Review

This review evaluates and explains our current understanding of a rare subtype of migraine, typical aura without headache, also known as migraine aura without headache or acephalgic migraine.

Recent Findings

Typical aura without headache is a known entity within the spectrum of migraine. Its pathophysiology is suggested to be similar to classic migraines, with cortical spreading depression leading to aura formation but without an associated headache. No clinical trials have been performed to evaluate treatment options, but case reports suggest that most patients will respond to the traditional treatments for migraine with aura. Bilateral greater occipital nerve blocks may be helpful in aborting migraine with prolonged aura. Transcranial magnetic stimulation has shown efficacy in aborting attacks of migraine with aura but has not been specifically tested in isolated aura.

Summary

Typical aura without headache occurs exclusively in 4% patients with migraine, and may take place at some point in 38% of patients with migraine with aura. Typical aura without headache commonly presents with visual aura without headache, brainstem aura without headache, and can also develop later in life, known as late-onset migraine accompaniment.
Literature
1.
go back to reference •• Headache Classification Committee of the International Headache Disorders. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. This new version of the ICHD is “Bible” for headache classification. •• Headache Classification Committee of the International Headache Disorders. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. This new version of the ICHD is “Bible” for headache classification.
2.
3.
go back to reference • Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. American migraine prevalence and prevention study (AMPP) advisory group. Migraine prevalence, disease burden and the need for preventive therapy. Neurology. 2007;68:343–9. The AMPP is a very large population survey which forms the basis for much of our knowledge about migraine epidemiology. CrossRef • Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. American migraine prevalence and prevention study (AMPP) advisory group. Migraine prevalence, disease burden and the need for preventive therapy. Neurology. 2007;68:343–9. The AMPP is a very large population survey which forms the basis for much of our knowledge about migraine epidemiology. CrossRef
4.
go back to reference • Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 1996;119(2):355–61. An older study of migraine aura symptoms in 163 patients to validate the ICHD criteria for migraine with aura. CrossRef • Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 1996;119(2):355–61. An older study of migraine aura symptoms in 163 patients to validate the ICHD criteria for migraine with aura. CrossRef
5.
go back to reference •• He Y, Li Y, Nie Z. Typical aura without headache: a case report and review of the literature. J Med Case Rep. 2015;9(1):40. A recent review of isolated migraine aura symptoms. •• He Y, Li Y, Nie Z. Typical aura without headache: a case report and review of the literature. J Med Case Rep. 2015;9(1):40. A recent review of isolated migraine aura symptoms.
6.
go back to reference • Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci. 1980;7(1):9–17. C. Miller Fisher’s classic articles describing late-life migraine accompaniments. • Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci. 1980;7(1):9–17. C. Miller Fisher’s classic articles describing late-life migraine accompaniments.
7.
go back to reference • Fisher CM. Late-life migraine accompaniments—further experience. Stroke. 1986;17(5):1033–42. C. Miller Fisher’s classic articles describing late-life migraine accompaniments. CrossRef • Fisher CM. Late-life migraine accompaniments—further experience. Stroke. 1986;17(5):1033–42. C. Miller Fisher’s classic articles describing late-life migraine accompaniments. CrossRef
8.
go back to reference Aiba S, Tatsumoto M, Saisu A, Iwanami H, Chiba K, Senoo T, et al. Prevalence of typical migraine aura without headache in Japanese ophthalmology clinics. Cephalalgia. 2010;30(8):962–7.CrossRef Aiba S, Tatsumoto M, Saisu A, Iwanami H, Chiba K, Senoo T, et al. Prevalence of typical migraine aura without headache in Japanese ophthalmology clinics. Cephalalgia. 2010;30(8):962–7.CrossRef
9.
go back to reference •• Vongvaivanich K, Lertakyamanee P, Silberstein SD, Dodick DW. Late-life migraine accompaniments: a narrative review. Cephalalgia. 2015;35:894–911. recent review of late-life migraine accompaniments. CrossRef •• Vongvaivanich K, Lertakyamanee P, Silberstein SD, Dodick DW. Late-life migraine accompaniments: a narrative review. Cephalalgia. 2015;35:894–911. recent review of late-life migraine accompaniments. CrossRef
10.
go back to reference Balestri M, Papetti L, Maiorani D, Capuano A, Tarantino S, Battan B, Vigevano F, Valeriani M Features of aura in paediatric migraine diagnosed using the ICHD 3 beta criteria. Cephalalgia 2017 (Epub ahead of print) PMID:29239213 Balestri M, Papetti L, Maiorani D, Capuano A, Tarantino S, Battan B, Vigevano F, Valeriani M Features of aura in paediatric migraine diagnosed using the ICHD 3 beta criteria. Cephalalgia 2017 (Epub ahead of print) PMID:29239213
11.
go back to reference Freedom T, Jay W. Migraine with and without headache. Semin Ophthalmol. 2003;18(4):210–7.CrossRef Freedom T, Jay W. Migraine with and without headache. Semin Ophthalmol. 2003;18(4):210–7.CrossRef
12.
13.
go back to reference Riffenburgh RS. Migraine equivalent: the scintillating scotoma. Ann Ophth. 1971;3(7):787–8. Riffenburgh RS. Migraine equivalent: the scintillating scotoma. Ann Ophth. 1971;3(7):787–8.
14.
go back to reference Raymond LA, Kranias G, Glueck M, Miller MA. Significance of scintillating scotoma of late onset. Surv Ophthalmol. 1980;25:107–13.CrossRef Raymond LA, Kranias G, Glueck M, Miller MA. Significance of scintillating scotoma of late onset. Surv Ophthalmol. 1980;25:107–13.CrossRef
15.
go back to reference O'Connor PS, Tredici TJ. Acephalgic migraine: fifteen years of experience. Ophthalmology. 1981;88(10):999–1003.CrossRef O'Connor PS, Tredici TJ. Acephalgic migraine: fifteen years of experience. Ophthalmology. 1981;88(10):999–1003.CrossRef
16.
go back to reference Yener AÜ, Korucu O. Visual field losses in patients with migraine without aura and tension-type headache. Neuro-Ophthalmol. 2017;41(2):59–67.CrossRef Yener AÜ, Korucu O. Visual field losses in patients with migraine without aura and tension-type headache. Neuro-Ophthalmol. 2017;41(2):59–67.CrossRef
17.
go back to reference Lewis RA, Vihayan N, Watson C, Keltner J, Johnson CA. Visual field loss in migraine. Ophthalmology. 1989;96(3):321–6.CrossRef Lewis RA, Vihayan N, Watson C, Keltner J, Johnson CA. Visual field loss in migraine. Ophthalmology. 1989;96(3):321–6.CrossRef
18.
go back to reference Grosberg BM, Solomon S, Lipton RB. Retinal migraine. Curr Pain Headache Rep. 2005;9:258–71.CrossRef Grosberg BM, Solomon S, Lipton RB. Retinal migraine. Curr Pain Headache Rep. 2005;9:258–71.CrossRef
19.
go back to reference • Grosberg BM, Solomon S, Lipton RB, Friedman DI. Retinal migraine reappraised. Cephalalgia. 2006;26:1275–86. This is a large series of patients with retinal migraine, emphasizing some atypical features which may occur but are not in ICHD. CrossRef • Grosberg BM, Solomon S, Lipton RB, Friedman DI. Retinal migraine reappraised. Cephalalgia. 2006;26:1275–86. This is a large series of patients with retinal migraine, emphasizing some atypical features which may occur but are not in ICHD. CrossRef
20.
go back to reference Jogi V, Mehta S, Bupta A, et al. More clinical observations on migraine associated with monocular visual symptoms in an Indian population. Ann Indian Acad Neurol. 2016;19(1):63–8.CrossRef Jogi V, Mehta S, Bupta A, et al. More clinical observations on migraine associated with monocular visual symptoms in an Indian population. Ann Indian Acad Neurol. 2016;19(1):63–8.CrossRef
21.
go back to reference Pula JH, Kwan K, Yuen CA, Kattah JC. Update on the evaluation of transient vision loss. Clin Ophthalmol. 2016;10:297–303.CrossRef Pula JH, Kwan K, Yuen CA, Kattah JC. Update on the evaluation of transient vision loss. Clin Ophthalmol. 2016;10:297–303.CrossRef
23.
go back to reference Marzoli SB, Criscuoli A. The role of visual system in migraine. Neurol Sci. 2017;38(1):99–102.CrossRef Marzoli SB, Criscuoli A. The role of visual system in migraine. Neurol Sci. 2017;38(1):99–102.CrossRef
24.
go back to reference Chaudhry P, Friedman DI. Hiccups as a migraine aura. Cephalalgia. 2014;35(9):831–4.CrossRef Chaudhry P, Friedman DI. Hiccups as a migraine aura. Cephalalgia. 2014;35(9):831–4.CrossRef
26.
go back to reference Taga A, Russo M, Genovese A, et al. A case-report of migraine “sine headache”. Cephalalgia. 2017;592-4(21):38. Taga A, Russo M, Genovese A, et al. A case-report of migraine “sine headache”. Cephalalgia. 2017;592-4(21):38.
27.
go back to reference •• Dodick DW. Migraine. Lancet. 2018;391:1315–30. A recent, comprehensive review of migraine pathophysiology. CrossRef •• Dodick DW. Migraine. Lancet. 2018;391:1315–30. A recent, comprehensive review of migraine pathophysiology. CrossRef
28.
go back to reference Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;48:4687–92.CrossRef Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;48:4687–92.CrossRef
29.
go back to reference Tfelt-Hansen PC. History of the migraine with aura and cortical spreading depression from 2941 and onwards. Cephalalgia. 2010;30:780–92.CrossRef Tfelt-Hansen PC. History of the migraine with aura and cortical spreading depression from 2941 and onwards. Cephalalgia. 2010;30:780–92.CrossRef
30.
go back to reference Schwedt TJ, Dodick DW. Advanced neuroimaging of migraine. Lancet Neurol. 2009;8(6):560–8.CrossRef Schwedt TJ, Dodick DW. Advanced neuroimaging of migraine. Lancet Neurol. 2009;8(6):560–8.CrossRef
31.
go back to reference Shibata K, Osawa M, Iwata M. Pattern reversal visual evoked potentials in migraine with aura and migraine aura without headache. Cephalalgia. 1998;18(6):319–23.CrossRef Shibata K, Osawa M, Iwata M. Pattern reversal visual evoked potentials in migraine with aura and migraine aura without headache. Cephalalgia. 1998;18(6):319–23.CrossRef
32.
go back to reference Arngrim N, Hougaard A, Ahmadi K, Vestergaard MG, et al. Heterogenous migraine aura symptoms correlate with visual cortex functional magnetic resonance imaging responses. Ann Neurol. 2017;82:925–39.CrossRef Arngrim N, Hougaard A, Ahmadi K, Vestergaard MG, et al. Heterogenous migraine aura symptoms correlate with visual cortex functional magnetic resonance imaging responses. Ann Neurol. 2017;82:925–39.CrossRef
33.
go back to reference Shin JH, Kim YK, Kim HJ, Kim JS. Altered brain metabolism in vestibular migraine; comparison of interictal and ictal findings. Cephalalgia. 2014;34:58–67.CrossRef Shin JH, Kim YK, Kim HJ, Kim JS. Altered brain metabolism in vestibular migraine; comparison of interictal and ictal findings. Cephalalgia. 2014;34:58–67.CrossRef
34.
go back to reference Hougaard A, Amin FM, Christiansen CE, et al. Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura. Brain. 2017;140:1633–42.CrossRef Hougaard A, Amin FM, Christiansen CE, et al. Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura. Brain. 2017;140:1633–42.CrossRef
35.
go back to reference Evans RW, Tietjen GE. Migrainous aura versus transient ischemic attack in an elderly migraineur. Headache. 2001;41(2):201–3.CrossRef Evans RW, Tietjen GE. Migrainous aura versus transient ischemic attack in an elderly migraineur. Headache. 2001;41(2):201–3.CrossRef
36.
go back to reference Dennis M, Warlow C. Migraine aura without headache: transient ischaemic attack or not? J Neurol Neurosurg Psychiatry. 1992;55(6):437–40.CrossRef Dennis M, Warlow C. Migraine aura without headache: transient ischaemic attack or not? J Neurol Neurosurg Psychiatry. 1992;55(6):437–40.CrossRef
37.
go back to reference De Simone R, Ranieri A, Marano E, Beneduce L, et al. Migraine and epilepsy: clinical and pathophysiological relations. Neurol Sci. 2007;28(2):S150–5.CrossRef De Simone R, Ranieri A, Marano E, Beneduce L, et al. Migraine and epilepsy: clinical and pathophysiological relations. Neurol Sci. 2007;28(2):S150–5.CrossRef
38.
go back to reference Muranaka H, Fujita H, Gotoa A, et al. Visual symptoms in epilepsy and migraine: localization and patterns. Epilepsia. 2001;42(1):62–6.CrossRef Muranaka H, Fujita H, Gotoa A, et al. Visual symptoms in epilepsy and migraine: localization and patterns. Epilepsia. 2001;42(1):62–6.CrossRef
39.
go back to reference Cianchetti C, Prun D, Ledda M. Epileptic seizures and headache/migraine: a review of types of association and terminology. Seizure. 2013;22(9):679–85.CrossRef Cianchetti C, Prun D, Ledda M. Epileptic seizures and headache/migraine: a review of types of association and terminology. Seizure. 2013;22(9):679–85.CrossRef
40.
go back to reference Kleinig TJ, Kiley M, Thompson PD. Acute convexity subarachnoid haemorrhage: a cause of aura-like symptoms in the elderly. Cephalalgia. 2008;28(6):658–63.CrossRef Kleinig TJ, Kiley M, Thompson PD. Acute convexity subarachnoid haemorrhage: a cause of aura-like symptoms in the elderly. Cephalalgia. 2008;28(6):658–63.CrossRef
41.
go back to reference Evans RW, Davidoff RA. Subarachnoid hemorrhage or migraine? Headache. 2001;41(1):99–101.CrossRef Evans RW, Davidoff RA. Subarachnoid hemorrhage or migraine? Headache. 2001;41(1):99–101.CrossRef
42.
go back to reference Friedman DI and Evans RW. Are blurred vision and short-duration visual phenomena migraine aura symptoms? Headache 2017;57:643–647. PMID: 28181231. Friedman DI and Evans RW. Are blurred vision and short-duration visual phenomena migraine aura symptoms? Headache 2017;57:643–647. PMID: 28181231.
43.
go back to reference Winterkorn JMS, Kupersmith MJ, Wirtshafter JD, Forman S. Treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med. 1993;329:396–8.CrossRef Winterkorn JMS, Kupersmith MJ, Wirtshafter JD, Forman S. Treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med. 1993;329:396–8.CrossRef
44.
go back to reference Burger SK, Saul RF, Selhorst JB, Thurston SE. Transient monocular blindness caused by vasospasm. N Engl J Med. 1991;325:870–3.CrossRef Burger SK, Saul RF, Selhorst JB, Thurston SE. Transient monocular blindness caused by vasospasm. N Engl J Med. 1991;325:870–3.CrossRef
45.
go back to reference • Ota I, Kuroshima K, Nagaoka T. Fundus video of retinal migraine. JAMA Ophthalmol. 2013;131:1481–2. This is a great video demonstrating retinal vascular narrowing during an episode of retinal migraine. CrossRef • Ota I, Kuroshima K, Nagaoka T. Fundus video of retinal migraine. JAMA Ophthalmol. 2013;131:1481–2. This is a great video demonstrating retinal vascular narrowing during an episode of retinal migraine. CrossRef
46.
go back to reference Wang Y, Li Y, Want M. Involvement of CGRP receptors in retinal spreading depression. Pharmacol Rep. 2016;68:935–8.CrossRef Wang Y, Li Y, Want M. Involvement of CGRP receptors in retinal spreading depression. Pharmacol Rep. 2016;68:935–8.CrossRef
47.
go back to reference Blixt FW, Radziwon-Balicka EL, et al. Distribution of CGRP and its receptor components CLR and RAMP1 in the rat retina. Exp Eye Res. 2017;161:124–31.CrossRef Blixt FW, Radziwon-Balicka EL, et al. Distribution of CGRP and its receptor components CLR and RAMP1 in the rat retina. Exp Eye Res. 2017;161:124–31.CrossRef
48.
go back to reference O’Sullivan F, Rossor M, Elston JS. Amaurosis fugax in young people. Br J Ophthalmol 292. 1992;76:660–2.CrossRef O’Sullivan F, Rossor M, Elston JS. Amaurosis fugax in young people. Br J Ophthalmol 292. 1992;76:660–2.CrossRef
49.
go back to reference Bigal ME, Lipton RB, Cohen J, Silberstein SD. Epilepsy and migraine. Epilepsy Behav. 2003;4:13–24.CrossRef Bigal ME, Lipton RB, Cohen J, Silberstein SD. Epilepsy and migraine. Epilepsy Behav. 2003;4:13–24.CrossRef
50.
go back to reference Queiroz LP, Friedman DI, Rapoport AM, Purdy A. Characteristics of migraine visual aura in Southern Brazil and Northern USA. Cephalalgia. 2011;31(16):1652–8.CrossRef Queiroz LP, Friedman DI, Rapoport AM, Purdy A. Characteristics of migraine visual aura in Southern Brazil and Northern USA. Cephalalgia. 2011;31(16):1652–8.CrossRef
51.
go back to reference Kupersmith MJ, Hass WK, Chase NE. Isoproterenol treatment of visual symptoms in migraine. Stroke. 1979;10(3):299–305.CrossRef Kupersmith MJ, Hass WK, Chase NE. Isoproterenol treatment of visual symptoms in migraine. Stroke. 1979;10(3):299–305.CrossRef
52.
go back to reference Goldner JA, Levitt LP. Treatment of complicated migraine with sublingual nifedipine. Headache. 1987;27(9):484–6.CrossRef Goldner JA, Levitt LP. Treatment of complicated migraine with sublingual nifedipine. Headache. 1987;27(9):484–6.CrossRef
53.
go back to reference Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology. 1997;48(1):261–2.CrossRef Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology. 1997;48(1):261–2.CrossRef
54.
go back to reference Kaube H, Hoerzog J, Käufer T, et al. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology. 2000;55(1):139–41.CrossRef Kaube H, Hoerzog J, Käufer T, et al. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology. 2000;55(1):139–41.CrossRef
55.
go back to reference Afridi SK, Griffin NJ, Kaube H, Goadsby PJ. A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology. 2013;80(7):642–7.CrossRef Afridi SK, Griffin NJ, Kaube H, Goadsby PJ. A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology. 2013;80(7):642–7.CrossRef
56.
go back to reference Rozen TD. Treatment of a prolonged migrainous aura with intravenous furosemide. Neurology. 2000;55(5):732–3.CrossRef Rozen TD. Treatment of a prolonged migrainous aura with intravenous furosemide. Neurology. 2000;55(5):732–3.CrossRef
57.
go back to reference Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology. 2000;55(10):1588–9.CrossRef Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology. 2000;55(10):1588–9.CrossRef
58.
go back to reference Lampl C, Katsarava Z, Diener HC, Limmroth V, et al. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry. 2005;76(12):1730–2.CrossRef Lampl C, Katsarava Z, Diener HC, Limmroth V, et al. Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry. 2005;76(12):1730–2.CrossRef
59.
go back to reference Allais G, D’Andrea G, Maggio M, Bennedetto C. The efficacy of ginkgolide B in the acute treatment of migraine aura: an open preliminary trial. Neurol Sci. 2013;34(1):S161–3.CrossRef Allais G, D’Andrea G, Maggio M, Bennedetto C. The efficacy of ginkgolide B in the acute treatment of migraine aura: an open preliminary trial. Neurol Sci. 2013;34(1):S161–3.CrossRef
60.
go back to reference Dahlöf CG, Hauge AW, Olesen J. Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study. Cephalalgia 2009;Supp 2:7–16.CrossRef Dahlöf CG, Hauge AW, Olesen J. Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study. Cephalalgia 2009;Supp 2:7–16.CrossRef
61.
go back to reference Silberstein SD, Schoenen J, Göbel H, Diener HC, Elkind AH, Klapper JA, et al. Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine. Cephalalgia. 2009;29(Suppl 2):17–27.CrossRef Silberstein SD, Schoenen J, Göbel H, Diener HC, Elkind AH, Klapper JA, et al. Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine. Cephalalgia. 2009;29(Suppl 2):17–27.CrossRef
62.
go back to reference • Cuadrado ML, Aledo-Serrano Á, López-Ruiz P, Gutiérrez-Viedma Á, Fernández C, Orviz A, et al. Greater occipital nerve block for the acute treatment of prolonged or persistent migraine aura. Cephalalgia. 2017;37(8):812–8. This study evaluated greater occipital nerve block for migraine aura status with positive results. CrossRef • Cuadrado ML, Aledo-Serrano Á, López-Ruiz P, Gutiérrez-Viedma Á, Fernández C, Orviz A, et al. Greater occipital nerve block for the acute treatment of prolonged or persistent migraine aura. Cephalalgia. 2017;37(8):812–8. This study evaluated greater occipital nerve block for migraine aura status with positive results. CrossRef
63.
go back to reference • Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomized, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9:373–80. Results of the clinical trial demonstrating efficacy of single-pulse transcranial magnetic stimulation for the acute treatment of migraine with aura. CrossRef • Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomized, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9:373–80. Results of the clinical trial demonstrating efficacy of single-pulse transcranial magnetic stimulation for the acute treatment of migraine with aura. CrossRef
Metadata
Title
Current Aura Without Headache
Authors
Divya R. Shah
Sonam Dilwali
Deborah I. Friedman
Publication date
01-11-2018
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 11/2018
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-018-0725-1

Other articles of this Issue 11/2018

Current Pain and Headache Reports 11/2018 Go to the issue

Other Pain (A Kaye and N Vadivelu, Section Editors)

The Evolution of Surgical Enhanced Recovery Pathways: a Review

Hot Topics in Pain and Headache (N Rosen, Section Editor)

The Evolving Landscape of Acute Pain Management in the Era of the Opioid Crisis

Hot Topics in Pain and Headache (N Rosen, Section Editor)

Naloxone Academic Detailing: Role of Community Outreach Teaching